|
Page 2
Symptoms
of mania and depression in children and adolescents may manifest
themselves through a variety of different behaviors. When manic,
children and adolescents, in contrast to adults, are more likely
to be irritable and prone to destructive outbursts than to be elated
or euphoric. When depressed, there may be many physical complaints
such as headaches, muscle aches, stomachaches or tiredness, frequent
absences from school or poor performance in school, talk of or efforts
to run away from home, irritability, complaining, unexplained crying,
social isolation, poor communication, and extreme sensitivity to
rejection or failure. Other manifestations of manic and depressive
states may include alcohol or substance abuse and difficulty with
relationships.
Existing
evidence indicates that bipolar disorder beginning in childhood
or early adolescence may be a different, possibly more severe form
of the illness than older adolescent-and adult-onset bipolar disorder.
When the illness begins before or soon after puberty, it is often
characterized by a continuous, rapid-cycling, irritable, and mixed
symptom state that may co-occur with disruptive behavior disorders,
particularly attention deficit hyperactivity disorder (ADHD) or
conduct disorder (CD), or may have features of these disorders as
initial symptoms. In contrast, later adolescent- or adult-onset
bipolar disorder tends to begin suddenly, often with a classic manic
episode, and to have a more episodic pattern with relatively stable
periods between episodes. There is also less co-occurring ADHD or
CD among those with later onset illness.
A child or adolescent who appears to be depressed and exhibits ADHD-like
symptoms that are very severe, with excessive temper outbursts and
mood changes, should be evaluated by a psychiatrist or psychologist
with experience in bipolar disorder, particularly if there is a
family history of the illness. This evaluation is especially important
since psychostimulant medications, often prescribed for ADHD, may
worsen manic symptoms. There is also limited evidence suggesting
that some of the symptoms of ADHD may be a forerunner of full-blown
mania.
Findings from an NIMH-supported study suggest that the illness may
be at least as common among youth as among adults. In this study,
one percent of adolescents ages 14 to 18 were found to have met
criteria for bipolar disorder or cyclothymia, a similar but milder
illness, in their lifetime. In addition, close to six percent of
adolescents in the study had experienced a distinct period of abnormally
and persistently elevated, expansive, or irritable mood even though
they never met full criteria for bipolar disorder or cyclothymia.
Compared to adolescents with a history of major depressive disorder
and to a never-mentally-ill group, both the teens with bipolar disorder
and those with subclinical symptoms had greater functional impairment
and higher rates of co-occurring illnesses (especially anxiety and
disruptive behavior disorders), suicide attempts, and mental health
services utilization. The study highlights the need for improved
recognition, treatment, and prevention of even the milder and subclinical
cases of bipolar disorder in adolescence.
Treatment
Once
the diagnosis of bipolar disorder is made, the treatment of children
and adolescents is based mainly on experience with adults, since
as yet there is very limited data on the efficacy and safety of
mood stabilizing medications in youth. The essential treatment for
this disorder in adults involves the use of appropriate doses of
mood stabilizers, most typically lithium and/or valproate, which
are often very effective for controlling mania and preventing recurrences
of manic and depressive episodes. Research on the effectiveness
of these and other medications in children and adolescents with
bipolar disorder is ongoing. In addition, studies are investigating
various forms of psychotherapy, including cognitive-behavioral therapy,
to complement medication treatment for this illness in young people.
Valproate
Use
According
to studies conducted in Finland in patients with epilepsy, valproate
may increase testosterone levels in teenage girls and produce polycystic
ovary syndrome in women who began taking the medication before age
20 5. Increased testosterone can lead to polycystic ovary syndrome
with irregular or absent menses, obesity, and abnormal growth of
hair. Therefore, young female patients taking valproate should be
monitored carefully by a physician.
NIMH
is attempting to fill the current gaps in treatment knowledge with
carefully designed studies involving children and adolescents with
bipolar disorder. Data from adults do not necessarily apply to younger
patients, because the differences in development may have implications
for treatment efficacy and safety 4. Current multi-site studies
funded by NIMH are investigating the value of long-term treatment
with lithium and other mood stabilizers in preventing recurrence
of bipolar disorder in adolescents. Specifically, these studies
aim to determine how well lithium and other mood stabilizers prevent
recurrences of mania or depression and control subclinical symptoms
in adolescents; to identify factors that predict outcome; and to
assess side effects and overall adherence to treatment. Another
NIMH-funded study is evaluating the safety and efficacy of valproate
for treatment of acute mania in children and adolescents, and also
is investigating the biological correlates of treatment response.
Other NIMH-supported investigators are studying the effects of antidepressant
medications added to mood stabilizers in the treatment of the depressive
phase of bipolar disorder in adolescents.
For
More Information
Office
of Communications and Public Liaison,
NIMH Information Resources and Inquiries Branch
6001 Executive Blvd., Room 8184, MSC 9663
Bethesda, MD 20892-9663
Phone: 301-443-4513
TTY: 301-443-8431
FAX: 301-443-4279 Mental Health
FAX4U: 301-443-5158
E-mail: nimhinfo@nih.gov
References
Carlson
GA, Jensen PS, Nottelmann ED, eds. Special issue: current issues
in childhood bipolarity. Journal of Affective Disorders, 1998;
51: entire issue.
Geller
B, Luby J. Child and adolescent bipolar disorder: a review of the
past 10 years. Journal of the American Academy of Child and Adolescent
Psychiatry, 1997; 36(9): 1168-76.
Lewinsohn
PM, Klein DN, Seely JR. Bipolar disorders in a community sample
of older adolescents: prevalence, phenomenology, comorbidity, and
course. Journal of the American Academy of Child and Adolescent
Psychiatry, 1995; 34(4): 454-63.
McClellan
J, Werry J. Practice parameters for the assessment and treatment
of adolescents with bipolar disorder. Journal of the American
Academy of Child and Adolescent Psychiatry, 1997; 36(Suppl 10):
157S-76S.
Vainionpaa
LK, Rattya J, Knip M, et al. Valproate-induced hyperandrogenism
during pubertal maturation in girls with epilepsy. Annuals of
Neurology, 1999; 45(4): 444-50.
Reprinted
with permission from
The National Institute of Mental Health
6001 Executive Boulevard
Bethesda, Maryland 20892-9663
www.nimh.nih.gov
|
|